• 中国科技论文统计源期刊(中国科技核心期刊)
  • 中国医药卫生核心期刊
  • 中国抗癌协会系列期刊

Choosing Wisely: Rational Option in Cancer Management
WU Yi-long
2014, 14(1): 1-3. DOI: 10.3969/j.issn.1671-5144.2014.01.001
Abstract PDF
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology
GOU Lan-ying, GAO Hong-fei, HAN Jie-fei, LIN Jun-tao, LI Wei, LOU Na-na, SUN Hui-wen, ZHANG Qi, ZHANG Qiu-yi, WU Yi-long
2014, 14(1): 4-29. DOI: 10.3969/j.issn.1671-5144.2014.01.002
Abstract PDF
Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer
MA Sheng-lin, LI An-na
2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
Abstract PDF
Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer
LIU Xiao-qing, LI Feng
2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
Abstract PDF
Identifying the Target NSCLC Patient for Maintenance Therapy: An Analysis from JMEN
LU Shun, AI Xing-hao, GOU Lan-ying
2014, 14(1): 37-40. DOI: 10.3969/j.issn.1671-5144.2014.01.005
Abstract PDF
Intercalated Combination of Chemotherapy and Erlotinib for Patients with Advanced Stage Non-Small Cell Lung Cancer: A Randomised, Double-Blind Trial
HUANG Cheng, LIN Gen, ZHAO Ning
2014, 14(1): 41-44. DOI: 10.3969/j.issn.1671-5144.2014.01.006
Abstract PDF
Efficacy Comparison of Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
HE Ya-yi, ZHOU Cai-cun, NIU Fei-yu
2014, 14(1): 45-47. DOI: 10.3969/j.issn.1671-5144.2014.01.007
Abstract PDF
The Clinical Characteristics and Efficacy of Non-Small Cell Lung Cancer Patients with HER2 Mutation
ZHAO Ming-fang, LIU Yun-peng, DENG Wei
2014, 14(1): 48-51. DOI: 10.3969/j.issn.1671-5144.2014.01.008
Abstract PDF
Gabexate Mesilate in Treating Acute Pancreatitis: A Systematic Review
SHEN Yong-hua, CHEN Min, ZHU Hao, ZOU Xiao-ping
2014, 14(1): 52-56. DOI: 10.3969/j.issn.1671-5144.2014.01.009
Abstract PDF
Association Between the Therapeutic Method of ERCP Combined with EST and PEP: A Meta-Analysis
YIN Yan-wei, ZHANG Jin-quan, SUN Qian-qian, HU Ai-min, LIU Hong-li, WANG Qi
2014, 14(1): 57-60. DOI: 10.3969/j.issn.1671-5144.2014.01.010
Abstract PDF
Identification between Recurrence and Pseudo-Progression after Chemoradiotherapy of Glioma
ZHANG Hong-dan, LI Wei-xiong, PAN Yi, ZENG Zi-jun, CHEN Zhi-yong
2014, 14(1): 61-64. DOI: 10.3969/j.issn.1671-5144.2014.01.011
Abstract PDF